Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Alabama guideAlabama Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Alabama
  4. ›Healthcare and Medical Services
  5. ›Genetic Testing -Death Investigation HM, MM, ME

Alabama Department of Forensic Sciences·Alabama

Genetic Testing -Death Investigation HM, MM, ME

Closes 2/19/2026$50k – $200kRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Alabama Department of Forensic Sciences seeks qualified vendors to provide genetic testing services for forensic death investigations when standard autopsy, toxicology, or injury evidence does not yield a clear cause or manner of death. Testing will be performed at three state‑run death investigation facilities in Huntsville, Montgomery, and Mobile. The solicitation is a Quick‑Quote (RFQ) and open for bidding from 13 Feb 2026 to 19 Feb 2026. Bidders must be registered in Alabama Buys and comply with all state procurement terms, including E‑Verify and electronic payment acceptance. • Service: DNA/Genetic analysis of decedent samples for identification and cause‑of‑death determination. • Locations: Huntsville Medical (5050 Technology Dr, Huntsville, AL 35805), Montgomery Medical (8160 AUM Dr, Montgomery, AL 36117), Mobile Medical (2 Forensic Dr, Mobile, AL 36617). • Contract type: Quick‑Quote (Request for Quotation) with a budget constraint; award will consider the agency’s budget limits. • Requirements: Vendor must supply qualified laboratory personnel, maintain chain‑of‑custody, provide results in a timely manner, and meet all statutory certifications (E‑Verify, debarment, etc.).

Attached files

Key dates

Opened
2/13/2026
Closes
2/19/2026

Last updated

Details

Type
Request for Quotation
Industry
Healthcare and Medical Services
NAICS
621511
Solicitation №
SRC0000032982

Budget estimate

$50,000 – $200,000

The solicitation does not disclose a contract ceiling. Assuming an average forensic DNA test cost of $300‑$500 per case and a modest annual volume of 200‑400 cases across the three facilities, the total contract value could range roughly between $60,000 and $200,000. Budget constraints mentioned by the agency suggest the lower end may be more likely, but the upper range remains plausible for a full‑service provider.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 71%

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

U.S. National Institutes of Health·United States of America

70% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

70% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

U.S. National Institutes of Health·United States of America

70% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. National Institutes of Health·United States of America

70% match

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

Closes 1/11/2027Opened 1/20/2026

U.S. National Institutes of Health·United States of America

69% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

68% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

68% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

LA County Coroner·California

68% match

As-Needed Forensic Pathology Services

Rolling / TBD closeOpened 9/17/2018

U.S. National Institutes of Health·United States of America

68% match

Research on the Ethical, Legal and Social Implications (ELSI) of Genomics

Closes 2/15/2027Opened 6/3/2026

U.S. National Institutes of Health·United States of America

67% match

Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

67% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

67% match

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. Department Of Health And Human Services·Maryland

66% match

NOI - DNA Sequencing of Bone Marrow Failure Syndro

Closes 11/2/2026Opened 10/22/2026

U.S. National Institutes of Health·United States of America

66% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. Health Resources and Services Administration·United States of America

66% match

Fetal, Infant, and Child Death Review Program

Closes 8/31/2028Opened 7/31/2026

U.S. National Institutes of Health·United States of America

66% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

66% match

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

66% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

66% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

66% match

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. Department Of The Interior·United States of America

65% match

Q--MOJAVE TORTOISE BIOINFORMATICS

Closes 10/31/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

65% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

65% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. National Institutes of Health·United States of America

65% match

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

Closes 11/18/2026Opened 10/30/2023